multiple myeloma is considered an incurable hematologic cancer but a subset of patients can achieve long-term remissions and survival. The present study examines the clinical features of long-term survival as it correlates to depth of disease response.
Usmani, S.Z., Hoering, A., Cavo, M., Miguel, J.S., Goldschimdt, H., Hajek, R., et al. (2018). Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma - an IMWG Research Project. BLOOD CANCER JOURNAL, 8(12), 123-123 [10.1038/s41408-018-0155-7].
Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma - an IMWG Research Project
Cavo, Michele;
2018
Abstract
multiple myeloma is considered an incurable hematologic cancer but a subset of patients can achieve long-term remissions and survival. The present study examines the clinical features of long-term survival as it correlates to depth of disease response.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
clinical predictors.pdf
accesso aperto
Tipo:
Versione (PDF) editoriale
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione
660.34 kB
Formato
Adobe PDF
|
660.34 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
